Safety and Efficacy of Botulinum Toxin A in Patients With Trigeminal Neuralgia
Clinical trial NCT06315790 · UNKNOWN
Trial details
- NCT number
- NCT06315790
- Sponsor
- Henrik Schytz
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2025-10-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.